HOME Intervention for Postpartum Health
(HOME Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve postpartum care for women who may face challenges after giving birth, focusing on reducing unnecessary emergency department visits and ensuring access to needed services. Participants will be divided into two groups: one will receive a helpful pamphlet and support from a patient navigator as part of the HOME Discharge Planning Intervention, while the other will receive standard care. The trial seeks postpartum women who have delivered at the Hospital of the University of Pennsylvania, identify as Black, speak English, and meet other risk factors. This initiative supports new mothers in managing health conditions like hypertension, diabetes, and depression. As an unphased trial, it offers participants the opportunity to contribute to innovative postpartum care solutions that could benefit future mothers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this educational intervention is safe for postpartum women?
Research has shown that education programs can improve care for new mothers after childbirth. One study on postpartum nursing programs found that they ease the transition from hospital to home. These programs provide essential medical advice and emotional support, helping mothers feel safer and more prepared after leaving the hospital.
Another review emphasizes the importance of education at discharge. It covers crucial safety topics like preventing falls, reducing infections, and recognizing postpartum depression. These programs ensure new mothers know when and how to seek help, teaching them to notice warning signs and act quickly.
In this trial, the HOME intervention provides new mothers with a pamphlet and access to a patient navigator, similar to the programs in the studies mentioned. The goal is to help mothers manage their health and connect them with useful resources. No harm or safety issues have been reported with these types of programs. Participants generally find them well-received and helpful.12345Why are researchers excited about this trial?
Researchers are excited about the HOME intervention for postpartum health because it offers a comprehensive and proactive approach to managing postpartum conditions like hypertension, diabetes, and depression. Unlike standard postpartum care, which typically involves routine check-ups and addressing issues as they arise, the HOME intervention provides tailored education through pamphlets and partner sheets, empowering new mothers with self-management skills and enhanced social support. Moreover, the involvement of a patient navigator who maintains regular contact with participants ensures ongoing support and connection to resources, which can significantly improve postpartum outcomes. This personalized and continuous support system sets the HOME intervention apart from typical postpartum care practices.
What evidence suggests that the HOME intervention is effective for improving postpartum care?
Studies show that postpartum care should be ongoing and personalized for each woman. Research indicates that good planning and education upon hospital discharge can improve health by connecting new mothers with the right resources and support. One study found that postpartum clinics focusing on issues like high blood pressure and offering lifestyle advice proved helpful. Although some research suggests that a single educational session might not reduce depression, ongoing support and personalized care can address various postpartum challenges. In this trial, one group will receive a patient education pamphlet and partner sheet, along with support from a patient navigator to provide comprehensive resources and fill gaps in care. Another group will receive standard postpartum care. This approach aims to provide essential support during the important postpartum period.34678
Are You a Good Fit for This Trial?
This trial is for postpartum Black women aged 18 or older who have recently delivered at the Hospital of University of Pennsylvania. Participants must speak English, be able to read, and meet certain risk criteria as determined by a prediction model.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a patient education pamphlet and partner sheet, and are supported by a patient navigator for 30 days postpartum
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on ED visits and readmissions
What Are the Treatments Tested in This Trial?
Interventions
- HOME
HOME is already approved in Canada for the following indications:
- Improving daily life activities for frail older adults
- Reducing hospital and emergency readmissions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Columbia University
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator